Puberty blockers should remain an option for trans youth: national advice
Puberty blockers should remain a clinical option for certain children with gender dysphoria despite limited evidence about their benefits and harms, according to long-awaited national advice.
Read at ABC NewsOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.